Dynamics in Post-pandemic Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry: Supply and Demand, Markets and Prices 2021-2027

Dynamics in Post-pandemic Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Industry: Supply and Demand, Markets and Prices 2021-2027

Report Code: KNJ661852 | No. of Pages: 136 | Category: Medical Devices
Publisher: GRD Survey | Date of Publish: Mar-2021
Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global NASH (Non-alcoholic Steatohepatitis) Biomarkers market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global NASH (Non-alcoholic Steatohepatitis) Biomarkers market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

Segmented by Category
Serum Biomarkers

Hepatic Fibrosis Biomarkers

Apoptosis Biomarkers

Oxidative Stress Biomarkers

Others

Segmented by End User/Segment
Pharma & CRO Industry

Hospitals

Diagnostic Labs

Academic Research Institutes

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
GENFIT SA

Pfizer Inc

Novo Nordisk A/S

Novartis AG

Gilead Sciences, Inc. (GILD)

Bristol-Myers Squibb Company

Boehringer Ingelheim

AstraZeneca

Allergan Plc



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status and Forecast (2016-2027)
        1.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Supply by Company
    2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Company
    2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Company
    2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Company
    2.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Production Location and Sales Area of Main Manufacturers
    2.5 Trend of Concentration Rate
3 Global and Regional NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by Category
    3.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Category Introduction
        3.1.1 Serum Biomarkers

        3.1.2 Hepatic Fibrosis Biomarkers

        3.1.3 Apoptosis Biomarkers

        3.1.4 Oxidative Stress Biomarkers

        3.1.5 Others
    3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Category
        3.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Category (2016-2021)
        3.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Category (2016-2021)
        3.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by Category (2016-2021)
    3.3 North America: by Category
    3.4 Europe: by Category
    3.5 Asia Pacific: by Category
    3.6 Central & South America: by Category
    3.7 Middle East & Africa: by Category
4 Global and Regional NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by End User/Segment
    4.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Segment by End User/Segment
        4.1.1 Pharma & CRO Industry

        4.1.2 Hospitals

        4.1.3 Diagnostic Labs

        4.1.4 Academic Research Institutes
    4.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by End User/Segment
        4.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by End User/Segment (2016-2021)
        4.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by End User/Segment (2016-2021)
        4.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price by End User/Segment (2016-2021)
    4.3 North America: by End User/Segment
    4.4 Europe: by End User/Segment
    4.5 Asia Pacific: by End User/Segment
    4.6 Central & South America: by End User/Segment
    4.7 Middle East & Africa: by End User/Segment
5 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status by Region
    5.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Region
        5.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Region
        5.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Region
    5.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    5.3 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    5.4 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    5.5 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    5.6 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
6 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    6.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country
        6.1.1 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021)
        6.1.2 North America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021)
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    7.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country
        7.1.1 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021)
        7.1.2 Europe NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021)
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
   8.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country
        8.1.1 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021)
        8.1.2 Asia Pacific NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021)
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    9.1 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country
        9.1.1 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021)
        9.1.2 Central & South America NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021)
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Status
    10.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Market by Country
        10.1.1 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume by Country (2016-2021)
        10.1.2 Middle East & Africa NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value by Country (2016-2021)
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
    11.1 Supply Chain Analysis
    11.2 Production Process Chart Analysis
    11.3 Raw Materials and Key Suppliers Analysis
        11.3.1 Raw Materials Introduction
        11.3.2 Raw Materials Key Suppliers List
    11.4 NASH (Non-alcoholic Steatohepatitis) Biomarkers Manufacturing Cost Analysis
    11.5 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Channel and Distributors Analysis
        11.5.1 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Channel
        11.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Distributors
    11.6 NASH (Non-alcoholic Steatohepatitis) Biomarkers Downstream Major Buyers
12 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Category and by End User/Segment
    12.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume and Sales Value Forecast (2022-2027)
    12.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by Category
        12.2.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by Category
        12.2.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by Category
        12.2.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by Category
    12.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Forecast by End User/Segment
        12.3.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by End User/Segment
        12.3.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by End User/Segment
        12.3.3 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Price Forecast by End User/Segment
13 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Region/Country
    13.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Market Forecast by Region (2022-2027)
        13.1.1 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume Forecast by Region (2022-2027)
        13.1.2 Global NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Value Forecast by Region (2022-2027)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 GENFIT SA

        14.1.1 Company Information
        14.1.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.1.3 GENFIT SA
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.1.4 SWOT Analysis
    14.2 Pfizer Inc

        14.2.1 Company Information
        14.2.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.2.3 Pfizer Inc
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.2.4 SWOT Analysis
    14.3 Novo Nordisk A/S

        14.3.1 Company Information
        14.3.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.3.3 Novo Nordisk A/S
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.3.4 SWOT Analysis
    14.4 Novartis AG

        14.4.1 Company Information
        14.4.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.4.3 Novartis AG
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.4.4 SWOT Analysis
    14.5 Gilead Sciences, Inc. (GILD)

        14.5.1 Company Information
        14.5.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.5.3 Gilead Sciences, Inc. (GILD)
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.5.4 SWOT Analysis
    14.6 Bristol-Myers Squibb Company

        14.6.1 Company Information
        14.6.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.6.3 Bristol-Myers Squibb Company
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.6.4 SWOT Analysis
    14.7 Boehringer Ingelheim

        14.7.1 Company Information
        14.7.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.7.3 Boehringer Ingelheim
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.7.4 SWOT Analysis
    14.8 AstraZeneca

        14.8.1 Company Information
        14.8.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.8.3 AstraZeneca
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.8.4 SWOT Analysis
    14.9 Allergan Plc

        14.9.1 Company Information
        14.9.2 NASH (Non-alcoholic Steatohepatitis) Biomarkers Product Introduction
        14.9.3 Allergan Plc
 NASH (Non-alcoholic Steatohepatitis) Biomarkers Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
        14.9.4 SWOT Analysis
15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com